An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.
Griffith
David E
DE
Aksamit
Timothy
T
Brown-Elliott
Barbara A
BA
Catanzaro
Antonino
A
Daley
Charles
C
Gordin
Fred
F
Holland
Steven M
SM
Horsburgh
Robert
R
Huitt
Gwen
G
Iademarco
Michael F
MF
Iseman
Michael
M
Olivier
Kenneth
K
Ruoss
Stephen
S
von Reyn
C Fordham
CF
Wallace
Richard J
RJ
Winthrop
Kevin
K
D000890:Anti-Infective Agents / Q000494:pharmacology; D001847:Bone Diseases / Q000175:diagnosis / Q000453:epidemiology / Q000382:microbiology / Q000628:therapy; D019411:Clinical Laboratory Techniques; D004196:Disease Outbreaks / Q000517:prevention & control; D024881:Drug Resistance, Bacterial; D005838:Genotype; D006801:Humans; D017053:Infection Control; D008171:Lung Diseases / Q000175:diagnosis* / Q000453:epidemiology / Q000382:microbiology / Q000628:therapy*; D008206:Lymphatic Diseases / Q000175:diagnosis / Q000453:epidemiology / Q000382:microbiology / Q000628:therapy; D009165:Mycobacterium Infections, Nontuberculous / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D012871:Skin Diseases / Q000175:diagnosis / Q000453:epidemiology / Q000382:microbiology / Q000628:therapy
D000890:Anti-Infective Agents